Global-Molecular-Breast-Imaging-Market-Trends-Industry-Outlook

Molecular Breast Imaging (MBI) represents an innovative approach in nuclear medicine, aimed at enhancing the detection and characterization of breast cancer, particularly in women with dense breast tissue where traditional mammography may fall short. Unlike standard imaging techniques that primarily focus on anatomical features, MBI emphasizes functional imaging by highlighting the metabolic activity within breast tissue. This methodology allows healthcare professionals to pinpoint malignant lesions based on their biological behavior, rather than relying solely on size or shape, thereby enhancing diagnostic confidence.